Nuevos horizontes en Cáncer de Páncreas

32 / 58

279 pts
 HA hight 84 pts (30%)
420 PTS
Placebo-Gem-Abx PEGPH20-Gem-Abx
Primary endpoints:
PFS / OS
P III HALO 301
mPC; HA hight
PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in PC